09/06/2015

ESTEVE RECEIVES ASPID AWARD FOR TRIPTOMAX

The Triptomax communication campaign has been awarded a silver ASPID in the category of Integrated Advertising. These Ibero-American Health and Pharmacy awards are granted every year to the best advertising works in Spain.

ESTEVE's Triptomax is a dietary supplement that helps naturally restore a positive mood. Its advertising campaign, consisting of TV commercials, external and in-store ads, and merchandising, has been awarded a silver ASPID in the 19th edition of these awards, held at the World Trade Center of Barcelona.

The Triptomax campaign targets people aged 35 to 55 years who are active but feel overwhelmed by different circumstances. Unlike the advertising of other multivitamin products, which address the problem or the need, this campaign focuses on the benefit provided by this product: seeing and living life in a positive way.

The Ibero-American Health and Pharmacy ASPID Awards are convened every year by the magazine PMFarma in collaboration with the Sepromark Marketing Club, and acknowledge the creativity in advertising pharmaceutical products and the communication of services related to health and healthcare.


You can follow ESTEVE on Twitter at this link: twitter.com/esteve_news.

Last news

  • THE PROGRAM ’PLAN PROFARMA’ HAS ONCE AGAIN QUALIFIED ESTEVE’S R&D&I AS ’’EXCELLENT’’

    Once again, ESTEVE's research activity has received the qualification ''Excellent'' in the Program 'Plan Profarma' (Program for Fostering Scientific Research, Technological Development and Innovation ...

    read more
  • PENSA PHARMA HAS BEEN AWARDED A PRIZE FOR ITS BEST DEVELOPMENT AND COMMERCIALIZATION OF GENERIC MEDICINES

    Pensa Pharma (PENSA), a company of the ESTEVE Group specialized in generic medicines, has been awarded a prize at the II edition of La Razón Comunidad Valenciana Awards. Specifically, PENSA has receiv...

    read more
  • ESTEVE APPOINTS THOMAS B. RIISAGER AS CHIEF CORPORATE STRATEGY & BUSINESS DEVELOPMENT OFFICER

    ESTEVE has announced today the appointment of Thomas B Riisager as Chief Corporate Strategy & Business Development Officer, to be heading Corporate Strategy & Business Development for the pharmaceutic...

    read more

Follow us at

This Website uses its own and third-party cookies to improve our services and analyse the user's browsing habits. If you continue browsing, we will consider you to have accepted their use. You can find more information by visiting our Cookies policy.